Publications by authors named "Ahd Hamidi"

Claim this Profile
S
Sabin inactivated polio vaccine upstream process development using fixed-bed bioreactor technology.
Ahd Hamidi, Marieke Willemsen, Thomas Robert, Jean-Christophe Drugmand, Mónika Z Ballmann

Vaccine· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High throughput AS LNA qPCR method for the detection of a specific mutation in poliovirus vaccine strains.
Lizet Opmeer, Isabella Gazzoli, Mónika Ballmann, Marieke Willemsen, Gerben P Voshol, Ahd Hamidi

Vaccine· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling the long-term 2-8 °C stability profiles of a live, rotavirus vaccine candidate (RV3-BB) in various liquid formulations via extrapolations of real-time and accelerated stability data.
Swathi R Pullagurla, Prashant Kumar, Oluwadara Ogun, Ozan S Kumru, Ahd Hamidi

Biologicals· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries.
Prashant Kumar, Ravi S Shukla, Ashaben Patel, Swathi R Pullagurla, Christopher Bird, Ahd Hamidi

Hum Vaccin Immunother· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine.
Ahd Hamidi, Femke Hoeksema, Pim Velthof, Angelique Lemckert, Gert Gillissen

Vaccine· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Formulation Variables on the Stability of a Live, Rotavirus (RV3-BB) Vaccine Candidate using in vitro Gastric Digestion Models to Mimic Oral Delivery.
Prashant Kumar, Swathi R Pullagurla, Ashaben Patel, Ravi S Shukla, Christopher Bird, Ahd Hamidi

J Pharm Sci· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of inactivated poliovirus vaccine from Sabin strains: A progress report.
Hiromasa Okayasu, Carolyn Sein, Ahd Hamidi, Wilfried A M Bakker, Roland W Sutter

Biologicals· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of immuno assays during the development of a Hemophilus influenzae type b vaccine for technology transfer to emerging vaccine manufacturers.
Ahd Hamidi, Hans Kreeftenberg

Hum Vaccin Immunother· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of a Haemophilus influenzae type b conjugate vaccine process intended for technology transfer.
Ahd Hamidi, Pauline Verdijk, Hans Kreeftenberg

Hum Vaccin Immunother· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Process development of a New Haemophilus influenzae type b conjugate vaccine and the use of mathematical modeling to identify process optimization possibilities.
Ahd Hamidi, Hans Kreeftenberg, Leo V D Pol, Saroj Ghimire, Luuk A M V D Wielen

Biotechnol Prog· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HPAEC-PAD quantification of Haemophilus influenzae type b polysaccharide in upstream and downstream samples.
Robert M F van der Put, Alex de Haan, Jan G M van den IJssel, Ahd Hamidi, Michel Beurret

Vaccine· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccinology capacity building in Europe for innovative platforms serving emerging markets.
Jan Hendriks, Marit Holleman, Ahd Hamidi, Michel Beurret, Claire Boog

Hum Vaccin Immunother· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovative IPV from attenuated Sabin poliovirus or newly designed alternative seed strains.
Ahd Hamidi, Wilfried A M Bakker

Pharm Pat Anal· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries.
Michel Beurret, Ahd Hamidi, Hans Kreeftenberg

Vaccine· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV.
Wilfried A M Bakker, Yvonne E Thomassen, Aart G van't Oever, Janny Westdijk, Monique G C T van Oijen, Ahd Hamidi

Vaccine· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis